Neurovia Bioelectronics
Developing blood pressure modulation devices.
Problem: Drug resistant hypertension and postural hypotension are diseases which have severe long term consequences and to this day no effective solution exists. Through our neural interface we are capable of modulating blood pressure in a minimally invasive intervention that lasts less than one hour after which patients can safely return home.
The founding team constitutes of Dr. William Esposito a postdoc at EPFL and me Omar Shalby an EPFL Neuro-X master student. Our expertise lies in material science, microfabrication and soft neural interfaces.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
22.09.2025
The first Batch of the HSG START Accelerator take off (startupticker.ch)
No milestones
Preclinical Study Lead
Engineering / Fulltime
We’re looking for a Preclinical Lead to take charge of our animal experimentation efforts. You’ll be based in Geneva and will travel frequently to Pisa to perform surgical implantations, data collection, and early-stage validation of our device.
No videos and documents
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Neurovia Bioelectronics
Developing blood pressure modulation devices.
Headquarter:
Ecublens
Foundation Date:
August 2025
Technology:
- Medtech
Sectors:
- Medical devices
- Medtech
Support received
